Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

GOAL.MD vs Vaylen

By GLP-1 ScorecardUpdated

GOAL.MD
Site position #159

Lower grade

Vaylen
Site position #46

Higher grade

Score comparison

Vaylen has the higher recorded score — 77.9/100 to 68.6/100.

Vaylen grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Vaylen is a pure GLP-1 specialist offering compounded semaglutide ($179/mo), compounded tirzepatide ($239/mo), compounded oral GLP-1 ($259/mo), and brand-name Ozempic, Zepbound, and Wegovy.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueVaylen +2
65
67
Dose & formulationVaylen +2
86
88
Clinical oversightVaylen +16
68
84
Labs & monitoringVaylen +24
53
77
FulfillmentVaylen +13
77
90
Contract termsEven
55
55
GOAL.MD · top barVaylen · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricGOAL.MDVaylen
WeighScore68.6/10077.9/100
GradeCC+
Site position#159#46
Semaglutide$179/mo (month-to-month, compounded)$179/mo (compounded)
Tirzepatide$249/mo (flat-dose monthly, compounded)$239/mo (compounded)
CoverageAdvertises all 50 states; clinical and pharmacy eligibility applyAll 50 states
Brand-name accessYesYes
Oral / sublingualYesYes
GOAL.MD

Site position #159 · C

Strengths

  • Compounded reorders require permission before charging
  • Advertised injection price stays the same across prescribed doses
  • Nutrition support and expedited shipping included in compounded plans
  • Advertises brand-name oral Wegovy access; medication costs extra

What to consider

  • Compounded orders become non-refundable when payment is processed
  • Lowest monthly equivalents require a twelve-month upfront payment
  • Brand-access page gives conflicting automatic-billing statements
  • Confirm the assigned dispensing pharmacy and its credentials
  • GOAL identifies a physician with historical discipline; Missouri ended restrictions in 2019 and records no current discipline at the October 2026 check
Vaylen

Site position #46 · C+

Strengths

  • Pure GLP-1 specialist — not a multi-category telehealth platform
  • All 50 states coverage with licensed clinicians
  • Both compounded and brand-name options (Ozempic, Wegovy, Zepbound)
  • Oral GLP-1 option (compounded dissolvable tablets) for needle-averse patients
  • LegitScript certified

What to consider

  • Compounded semaglutide at $179/mo is mid-range (not the cheapest)
  • Brand-name options at near-retail pricing ($997-$1,086/mo)

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard